These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The influence of thermal trauma on pro- and anticoagulant activity of erythrocyte-derived microvesicles. Levin G; Sukhareva E Burns; 2016 Nov; 42(7):1528-1533. PubMed ID: 27268106 [TBL] [Abstract][Full Text] [Related]
4. Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography. Hacquard M; Perrin J; Lelievre N; Vigneron C; Lecompte T Thromb Res; 2011 Jan; 127(1):29-34. PubMed ID: 20850172 [TBL] [Abstract][Full Text] [Related]
5. Effects of erythrocyte microvesicles on the coagulation process stages. Levin GY; Sukhareva EG; Egorikhina MN Bull Exp Biol Med; 2013 Nov; 156(1):32-4. PubMed ID: 24319721 [TBL] [Abstract][Full Text] [Related]
7. [Thrombin]. Camici M; Sagripanti A; Di Mitri R Minerva Med; 2000; 91(5-6):105-12. PubMed ID: 11084844 [TBL] [Abstract][Full Text] [Related]
8. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin. Elgue G; Blombäck M; Olsson P; Riesenfeld J Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137 [TBL] [Abstract][Full Text] [Related]
9. Differences in the effect of antithrombin on thrombin clotting and thrombin esterase activity. Gans H; Boulton A Thromb Diath Haemorrh; 1969 Aug; 22(1):28-31. PubMed ID: 5821245 [No Abstract] [Full Text] [Related]
10. Bioregulatory roles for fibrin(ogen) on blood coagulation. Okwusidi JI; Ofosu FA Med Hypotheses; 1992 Oct; 39(2):152-5. PubMed ID: 1461178 [TBL] [Abstract][Full Text] [Related]
11. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays. Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195 [TBL] [Abstract][Full Text] [Related]
12. Prothrombin and antithrombin: their opposing functions in blood coagulation. Grannis GF; Kazal LA Thromb Diath Haemorrh; 1966 Dec; 16(3):497-506. PubMed ID: 5996671 [No Abstract] [Full Text] [Related]
13. Photometric assay of antithrombin III with a chromogenic substrate. Vinazzer H Haemostasis; 1975; 4(2):101-9. PubMed ID: 1205336 [TBL] [Abstract][Full Text] [Related]
15. Iron-Driven Alterations on Red Blood Cell-Derived Microvesicles Amplify Coagulation during Hemolysis via the Intrinsic Tenase Complex. Delvasto-Núñez L; Roem D; Bakhtiari K; van Mierlo G; Meijers JCM; Jongerius I; Zeerleder SS Thromb Haemost; 2022 Jan; 122(1):80-91. PubMed ID: 33940654 [TBL] [Abstract][Full Text] [Related]
16. Anti-heparin activity of lysosomal cationic proteins from polymorphonuclear leukocytes. Saba HI; Roberts HR; Herion JC Blood; 1968 Mar; 31(3):369-80. PubMed ID: 5640632 [No Abstract] [Full Text] [Related]
17. Platelet Microvesicles (Microparticles) in Cardiac Surgery. Tempo JA; Englyst NA; Holloway JA; Smith DC J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):222-8. PubMed ID: 26597471 [No Abstract] [Full Text] [Related]
18. Elevated levels of thrombin-generating microparticles in stored red blood cells. Gao Y; Lv L; Liu S; Ma G; Su Y Vox Sang; 2013 Jul; 105(1):11-7. PubMed ID: 23347295 [TBL] [Abstract][Full Text] [Related]
19. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture. Seegers WH Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919 [TBL] [Abstract][Full Text] [Related]
20. The importance of anti-factor Xa and antithrombin activities of low molecular weight heparins. Lane DA; Ryan K J Lab Clin Med; 1990 Aug; 116(2):269-70. PubMed ID: 2394942 [No Abstract] [Full Text] [Related] [Next] [New Search]